secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001213900-25-093936
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies files prospectus supplement for resale of up to 4.37M shares by selling stockholders
--------------------------------------------------------------------------------

- Prospectus supplement covers resale of up to 4,373,043 shares of common stock by selling stockholders.
- Shares are being registered for resale under existing S-3 shelf (File No. 333-289443) declared effective August 12, 2025.
- Company is not issuing new shares or raising capital from this resale registration.
- Legal opinion on share legality from Olshan Frome Wolosky LLP filed as Exhibit 5.1.
- Filing date: September 30, 2025; no change in business operations or financial guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025093936/0001213900-25-093936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025093936/ea0259321-8k_ostherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-093936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer